Antidepressant treatment of juvenile depression

International Journal of Psychiatry in Clinical Practice

Volumn 3, Issue 3, 1999, Pages 171-179

  Bostic, Jeff Q ^a   Wilens, Timothy E ^a   Spencer, Thomas ^a   Biederman, Joseph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adolescent; Children; Depression; Mood disorder; Psychopharmacology

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ASTEMIZOLE; BEFLOXATONE; CISAPRIDE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOPAMINE; ERYTHROMYCIN; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TERFENADINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; AFFECTIVE NEUROSIS; AGITATION; ANOREXIA NERVOSA; ATTENTION DEFICIT DISORDER; BULIMIA; CHILD; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DYSTHYMIA; ENURESIS; GILLES DE LA TOURETTE SYNDROME; HUMAN; INSOMNIA; IRRITABILITY; NAUSEA; OBSESSION; PRIORITY JOURNAL; REVIEW;

EID: 0032878635     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509909022730     Document Type: Review

References (85)

1. Lewinsohn P, Clarke GN, Seeley JR, Rohde P (1994) Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 33: 809-18.
2. Puig-Antich J, Luken E, Davies M et al (1985) Psychosocial functioning in prepubertal major depressive disorders: II. Arch Gen Psychiatry 42: 511-7.
3. Kovacs M (1996) Presentation and course of major depressive disorder during childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry 35: 705-15.
4. Harrington RC (1996) Adult outcomes of childhood and adolescent depression: Influences on the risk for adult depression. Psychiatric Ann 26: 320-5.
5. Puig-Antich J, Goetz D, Davies M et al (1989) A controlled family history study of prepubertal major depressive disorder. Arch Gen Psychiatry 46: 406-18.
6. Aylward GP (1985) Understanding and treatment of childhood depression. J Pediatr 107: 1-9.
7. Kaminski KM, Naylor MW, King CA, Ghaziuddin N (1995) Reactive mood and atypical depression in psychiatrically hospitalized depressed adolescents. Depression 3: 176-81.
8. Kashani JH, Sherman DD (1989) Mood disorders in children and adolescents. In: Review of Psychiatry, 197-217. American Psychiatric Press, Washington DC.
9. Chambers WJ, Puig-Antich J, Tabrizi MA, Davies M (1982) Psychotic depression symptoms in prepubertal major depressive disorder. Arch Gen Psychiatry 39: 921-7.
10. Geller B, Fox LW, Clark KA (1994) Rate and predictors of prepubertal bipolarity during follow-up of 6-to 12-year-old children. J Am Acad Child Adolesc Psychiatry 33: 461-8.
11. Bowden CL, Rhodes LJ (1996) Mania in children and adolescents: Recognition and treatment. Psychiatric Ann 26 (suppl): 430-4.
12. Moreau DL (1990) Major depression in childhood and adolescence. Psychiatric Clin N Am 13: 355-68.
13. Bostic JQ, Wilens TE, Spencer T, Biederman J (1997) Juvenile mood disorders and office psychopharmacology. Pediatr Clin North Am 44: 1487-1503.
14. Jacobsen LK, Rabinowitz I, Popper MS et al (1994) Interviewing prepubertal children about suicidal ideation and behavior. J Am Acad Child Adolesc Psychiatry 33: 439-52.
15. Birmaher B (1998) Should we use antidepressant medications for children and adolescents with depressive disorders? Psychopharmacol Bull 34: 35-9.
16. Ryan ND, Puig-Antich J, Rabinovich H et al (1988) MAOIs in adolescent major depression unresponsive to tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry 27: 755-8.
17. Sambunaris A, Keppel Hesselink J, Pinder R et al (1997) Development of new antidepressants. J Clin Psychiatry 58 (suppl 6): 40-53.
18. Rush AJ, Golden WE, Hall GW et al (1993) Depression in primary care. Vol. 2. Treatment of major depression. Clinical practice guideline, No. 5. AHCPR Publication No. 93-0551. US Department of Health & Human Services, Public Health Service, Agency for Health Care Policy and Research. Rockville, MD.
19. Puig-Antich J, Weston B (1983) The diagnosis and treatment of major depressive disorder in childhood. Annu Rev Med 34: 231-45.
20. Geller B, Cooper T, Graham D et al (1992) Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6-to 12-year-olds with major depressive disorder. J Am Acad Child Adolesc Psychiatry 31: 34-44.
21. Geller B, Cooper T, Graham D et al (1990) Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a 'fixed plasma level' design. Psychopharmacol Bull 26: 85-90.
22. Geller B, Todd RD, Luby J, Botteron KN (1996) Treatment-resistant depression in children and adolescents. Psychiatr Clin North Am 19: 253-67.
23. Goldman-Rakic P, Brown R (1982) Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res 4: 339-49.
24. Emslie GJ, Rush AJ, Weinberg WA et al (1997) A double-blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents. Arch Gen Psychiatry 54: 1031-7.
25. Wagner KD, Birmaher B, Carlson G et al (1998) Safety of paroxetine and imipramine in the treatment of adolescent depression. 151st Meeting of the American Psychiatric Association, Toronto, May 1998. APA, Washington DC.
26. Simeon J, Dinicola V, Ferguson H, Copping W (1990) Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharm Biol Psychiatry 14: 791-5.
27. Mandoki MW, Tapia MR, Tapia MA et al (1997) Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull 33: 149-54.
28. Findling RL (1996) Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: A case series. J Child Adolesc Psychopharmacol 6: 165-75.
29. Gammon GD, Brown TE (1993) Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 3: 1-10.
30. Jain U, Birmaher B, Garcia M et al (1992) Fluoxetine in children and adolescents with mood disorders: A chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol 2: 259-65.
31. Wilens TE, Spencer TJ, Biederman J, Schliefer D (1997) Case study: Nefazodone for juvenile mood disorders. J Am Acad Child Adolesc Psychiatry 36: 481-5.
32. Fairbanks JM, Pine DS, Tancer NK et al (1997) Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol 7: 17-29.
33. Riddle MA, Scahill L, King RA et al (1992) Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 31: 1062-9.
34. Alderman J, Wolkow R, Chung M, Johnston HF (1998) Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: Pharmacokinetics, tolerability, and efficacy. J Am Acad Child Adolesc Psychiatry 37: 386-91.
35. Johnston HF (1993) The efficacy of sertraline and behavior therapy in adolescents with treatment resistant OCD. 146th Annual Meeting of the American Psychiatric Association, San Francisco, CA, May 1993. APA, Washington, DC.
36. March JS, Biederman J, Wolkow R et al (1998) Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. JAMA 280: 1752-6.
37. Apter A, Ratzoni G, King RA et al (1994) Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry 33: 342-8.
38. Casat CD, Pleasants DZ, Van Wyck Fleet J (1987) A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacol Bull 23: 120-2.
39. Olvera RL, Pliszka SP, Luh J, Tatum R (1996) An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol 6: 241-50.
40. Thomsen PH (1997) Child and adolescent obsessive-compulsive disorder treated with citalopram: Findings from an open trial of 23 cases. J Child Adolesc Psychophannacol 7: 157-66.
41. Lepola U, Leinonen E, Koponen H (1996) Citalopram in the treatment of early-onset panic disorder and school phobia. Pharmacopsychiatry 29: 30-32.
42. Findling RL, Magnus RD, Marcus RN et al (1998) An open-label pharmacokinetic trial of nefazodone in depressed children and adolescents. Proceedings of the American Psychiatric Association, Toronto, June 1988. APA, Washington.
43. Wilens TE, Biederman J, March J et al (1999) Absence of cardiovascular effects of sertraline in children and adolescents. J Am Acad Child Adolesc Psychiatry (in press).
44. Isacsson G, Bergman U, Rich CL (1996) Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affective Disord 41: 1-8.
45. Forder J, Kavanagh S, Fenyo A (1996) A comparison of sertraline versus tricyclic antidepressants in primary care. J Affective Disord 38: 97-111.
46. Sclar DA, Skaer TL, Robison LM et al (1998) Economic outcomes with antidepressant pharmacotherapy: A retrospective intent-to-treat analysis. J Clin Psychiatr 59 (suppl 2): 13-17.
47. Emslie GJ, Rush AJ, Weinberg WA et al (1998) Fluoxetine in child and adolescent depression: Acute and maintenance treatment. Depress Anxiety 7: 32-39.
48. Ten Eick AP, Nakamura H, Reed MD (1998) Drug-drug interactions in pediatric psychopharmacology. Pediatr Clin North Am 45: 1233-64.
49. Physicians' Desk Reference. 52nd edn (1998) Medical Economics, Montvale, NJ.
50. Goodnick PJ, Jorge CM, Hunter TA, Kumar A (1998) Nefazodone in adolescent depression. Proceedings of the American Psychiatric Association, Toronto, June 1998: 253. APA, Washington, DC.
51. Kallepalli BR, Bhatara VS, Fogas BS et al (1997) Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders. J Child Adolesc Psychopharmacol 7: 97-107.
52. Bodkin JA, Lasser RA, Wines JD, Jr et al (1997) Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry 58: 137-145.
53. Apter JT, Kushner SF, Woolfolk RL (1994) Bupropion/ nortriptyline combinations for refractory depression. Ann Clin Psychiatry 6: 255-8.
54. Sachs GS, Lafer B, Stoll AL et al (1994) A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 55: 391-3.
55. Stoll AL, Mayer PV, Kolbrener M et al (1994) Antidepressant-associated mania: A controlled comparison with spontaneous mania. Am J Psychiatry 151: 1642-5.
56. Quitkin FM, McGrath PJ, Stewart JW et al (1996) Chronological milestones to guide drug change. When should clinicians switch antidepressants? Arch Gen Psychiatry 53: 785-92.
57. Biederman J, Thisted R, Greenhill L et al (1995) Estimation of the association between desipramine and the risk for sudden death in 5-to 14-year-old children. J Clin Psychiatry 56: 87-93.
58. Wilens TE, Biederman J, Baldessarini RJ et al (1996) Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 35: 1491-1501.
59. Rapport MD, Carlson GA, Kelly KL, Pataki C (1993) Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function. J Am Acad Child Adolesc Psychiatry 32: 333-42.
60. Relling MV, Mulhern RK, Dodge RK et al (1989) Lorazepam pharmacodynamics and pharmacokinetics in children. J Pediatr 114: 641-6.
61. Ryan ND, Meyer V, Dachille S et al (1988) Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry 27: 371-6.
62. Petti TA, Law WL, III (1982) Imipramine treatment of depressed children: A double-blind pilot study. J Clin Psychopharmacol 2: 107-110.
63. Kashani JH, Shekim W, Reid J (1984) Amitriptyline in children with major depressive disorder: A double-blind crossover pilot study. J Am Acad Child Adolesc Psychiatry 23: 348-51.
64. Preskorn SH, Weller EB, Hughes CW et al (1987) Depression in prepubertal children: Dexamethasone nonsuppression predicts differential response to imipramine vs. placebo. Psychopharmacol Bull 23: 128-133.
65. Puig-Antich J, Perel JM, Lupatkin W et al (1987) Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry 44: 81-9.
66. Geller B, Cooper T, McCombs HG et al (1989) Double-blind, placebo-controlled study of nortriptyline in depressed children using a 'fixed plasma level' design. Psychopharmacol Bull 25: 101-8.
67. Hughes DC, Preskom SH, Wrona M et al (1990) Follow up of adolescents initially treated for prepubertal-onset major depressive disorder with imipramine. Psychopharmacol Bull 26: 244-8.
68. Kramer AD, Feiguine RJ (1981) Clinical effects of amitriptyline in adolescent depression. J Am Acad Child Adolesc Psychiatry 20: 636-44.
69. Koplewicz H, Klein R (1990) Desipramine treatment in adolescent depression. Child Depression Consortium Meeting, Pittsburgh, PA, 1990.
70. Kutcher S, Boulos C, Ward B et al (1994). Response to desipramine treatment in adolescent depression: A fixed-dose, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 33: 686-94.
71. Kye C, Waterman GS, Ryan ND et al (1996) A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. J Am Acad Child Adolesc Psychiatry 35: 1139-44.
72. Birmaher B, Waterman GS, Ryan ND et al (1998) Randomized, controlled trial of amitriptyline versus placebo for adolescents with 'treatment-resistant' major depression. J Am Acad Child Adolesc Psychiatry 37: 527-35.
73. Boulos C, Kutcher S, Gardner D, Young E (1992) An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant depression. J Child Adolesc Psychopharmacol 2: 103-111.
74. Colle LM, Belair JF, DiFeo M et al (1994) Extended open-label fluoxetine treatment of adolescents with major depression. J Child Adolesc Psychopharmacol 4: 225-32.
75. Ghaziuddin N, Naylor MW, King CA (1995) Fluoxetine in tricyclic refractory depression in adolescents. Depression 2: 287-91.
76. Nguyen N, Bui B, Whittlesey S et al (1995) A pilot study: Pattern analysis of fluoxetine in childhood depression. Psychopharm Bull 31: 602.
77. Riggs PD, Mikulich SK, Coffman LM, Crowley TJ (1997) Fluoxetine in drug-dependent delinquents with major depression: An open trial. J Child Adolesc Psychopharmacol 7: 87-95.
78. McConville BJ, Minnery KL, Sorter MT et al (1996) An open study of the effects of sertaline on adolescent major depression. J Child Adolesc Psychopharmacol 6: 41-51.
79. Milin R, Simeon JG, Nixon MK et al (1997) Adolescent dysthmia: An open clinical trial with sertraline. 44th Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, October 1997.
80. Rey-Sanchez F, Gutierrez-Casares JR (1997) Paroxetine in children with major depressive disorder: An open trial. J Am Acad Child Adolesc Psychiatry 36: 1443-7.
81. Levi G, Sogos O (1997) Depressive disorder in pre-adolescence: Comorbidity or different clinical subtypes. Isr J Psychiatry Relat Sci 34: 187-94.
82. Arredondo DE (1993) Bupropion treatment of adolescent depression. 146th Annual Meeting of the American Psychiatric Association, San Francisco, CA. APA, Washington, DC.
83. Cosgrove PVF (1994) Fluvoxamine in the treatment of depressive illness in children and adolescents. J Psychopharm 8: 118-23.
84. Tierney E, Joshi PT, Llinas JF et al (1995) Sertraline for major depression in children and adolescents: Preliminary clinical experience. J Child Adolesc Psychopharmacol 5: 13-27.
85. Masi G, Marcheschi M, Pfanner P (1997) Paroxetine in depressed adolescents with intellectual disability: an open label study. J Intellect Disabil Res 41: 268-72.